Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours. [electronic resource] by
- Lê, Lyly H
- Moore, Malcolm J
- Siu, Lillian L
- Oza, Amit M
- MacLean, Martha
- Fisher, Bryn
- Chaudhary, Ajai
- de Alwis, Dinesh P
- Slapak, Christopher
- Seymour, Lesley
Producer: 20050802
In:
Cancer chemotherapy and pharmacology vol. 56
Availability: No items available.
|
|
5.
|
A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy. [electronic resource] by
- Sandler, Alan
- Gordon, Michael
- De Alwis, Dinesh P
- Pouliquen, Isabelle
- Green, Lisa
- Marder, Phil
- Chaudhary, Ajai
- Fife, Karen
- Battiato, Linda
- Sweeney, Christopher
- Jordan, Christopher
- Burgess, Michael
- Slapak, Christopher A
Producer: 20041210
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 10
Availability: No items available.
|
|
6.
|
A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells. [electronic resource] by
- Hu, Yi
- Stephen, Andrew G
- Cao, Jin
- Tanzer, Lee R
- Slapak, Christopher A
- Harrison, Steadman D
- Devanarayan, Viswanath
- Dantzig, Anne H
- Starling, James J
- Rome, Leonard H
- Moore, Robert E
Producer: 20020117
In:
International journal of cancer vol. 97
Availability: No items available.
|
|
7.
|
Oral administration of gemcitabine in patients with refractory tumors: a clinical and pharmacologic study. [electronic resource] by
- Veltkamp, Stephan A
- Jansen, Robert S
- Callies, Sophie
- Pluim, Dick
- Visseren-Grul, Carla M
- Rosing, Hilde
- Kloeker-Rhoades, Susanne
- Andre, Valerie A M
- Beijnen, Jos H
- Slapak, Christopher A
- Schellens, Jan H M
Producer: 20080828
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 14
Availability: No items available.
|
|
8.
|
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. [electronic resource] by
- Herbertz, Stephan
- Sawyer, J Scott
- Stauber, Anja J
- Gueorguieva, Ivelina
- Driscoll, Kyla E
- Estrem, Shawn T
- Cleverly, Ann L
- Desaiah, Durisala
- Guba, Susan C
- Benhadji, Karim A
- Slapak, Christopher A
- Lahn, Michael M
Producer: 20160603
In:
Drug design, development and therapy vol. 9
Availability: No items available.
|
|
9.
|
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia. [electronic resource] by
- Vadhan-Raj, Saroj
- Abonour, Rafat
- Goldman, Jonathan W
- Smith, David A
- Slapak, Christopher A
- Ilaria, Robert L
- Tiu, Ramon V
- Wang, Xuejing
- Callies, Sophie
- Cox, Joanne
- Tuttle, Jay L
- Lau, Yiu-Keung
- Roeland, Eric J
Producer: 20171201
In:
Journal of hematology & oncology vol. 10
Availability: No items available.
|
|
10.
|
Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transporters. [electronic resource] by
- Dantzig, Anne H
- Shepard, Robert L
- Pratt, Susan E
- Tabas, Linda B
- Lander, Peter A
- Ma, Liandong
- Paul, Donald C
- Williams, Daniel C
- Peng, Sheng-Bin
- Slapak, Christopher A
- Godinot, Nathalie
- Perry, William L
Producer: 20040412
In:
Biochemical pharmacology vol. 67
Availability: No items available.
|
|
11.
|
Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study. [electronic resource] by
- Talbot, Denis C
- Ranson, Malcolm
- Davies, Joanna
- Lahn, Michael
- Callies, Sophie
- André, Valérie
- Kadam, Sunil
- Burgess, Michael
- Slapak, Christopher
- Olsen, Anna L
- McHugh, Peter J
- de Bono, Johann S
- Matthews, Julian
- Saleem, Azeem
- Price, Patricia
Producer: 20110404
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16
Availability: No items available.
|
|
12.
|
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors. [electronic resource] by
- Simon, George R
- Ilaria, Robert L
- Sovak, Mika A
- Williams, Charles C
- Haura, Eric B
- Cleverly, Ann L
- Sykes, Amanda K
- Wagner, Margaret M
- de Alwis, Dinesh P
- Slapak, Christopher A
- Miller, Mary A
- Spriggs, David R
Producer: 20111227
In:
Cancer chemotherapy and pharmacology vol. 68
Availability: No items available.
|
|
13.
|
A phase I trial of a potent P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), administered orally in combination with doxorubicin in patients with advanced malignancies. [electronic resource] by
- Rubin, Eric H
- de Alwis, Dinesh P
- Pouliquen, Isabelle
- Green, Lisa
- Marder, Phil
- Lin, Yong
- Musanti, Rita
- Grospe, Stephanie L
- Smith, Sharon L
- Toppmeyer, Deborah L
- Much, Judy
- Kane, Michael
- Chaudhary, Ajai
- Jordan, Christopher
- Burgess, Michael
- Slapak, Christopher A
Producer: 20030121
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 8
Availability: No items available.
|
|
14.
|
Results of a phase 1 study of AME-133v (LY2469298), an Fc-engineered humanized monoclonal anti-CD20 antibody, in FcγRIIIa-genotyped patients with previously treated follicular lymphoma. [electronic resource] by
- Forero-Torres, Andres
- de Vos, Sven
- Pohlman, Brad L
- Pashkevich, Maksim
- Cronier, Damien M
- Dang, Nam H
- Carpenter, Susan P
- Allan, Barrett W
- Nelson, James G
- Slapak, Christopher A
- Smith, Mitchell R
- Link, Brian K
- Wooldridge, James E
- Ganjoo, Kristen N
Producer: 20120626
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18
Availability: No items available.
|
|
15.
|
Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors. [electronic resource] by
- Koolen, Stijn L W
- Witteveen, Petronella O
- Jansen, Robert S
- Langenberg, Marlies H G
- Kronemeijer, Roelien H
- Nol, Annemarie
- Garcia-Ribas, Ignacio
- Callies, Sophie
- Benhadji, Karim A
- Slapak, Christopher A
- Beijnen, Jos H
- Voest, Emile E
- Schellens, Jan H M
Producer: 20120117
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17
Availability: No items available.
|
|
16.
|
Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies. [electronic resource] by
- Fracasso, Paula M
- Goldstein, Lori J
- de Alwis, Dinesh P
- Rader, Janet S
- Arquette, Matthew A
- Goodner, Sherry A
- Wright, Lisa P
- Fears, Carole L
- Gazak, Robert J
- Andre, Valerie A M
- Burgess, Michael F
- Slapak, Christopher A
- Schellens, Jan H M
Producer: 20050503
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 10
Availability: No items available.
|
|
17.
|
Phase 1/2 study of ocaratuzumab, an Fc-engineered humanized anti-CD20 monoclonal antibody, in low-affinity FcγRIIIa patients with previously treated follicular lymphoma. [electronic resource] by
- Ganjoo, Kristen N
- de Vos, Sven
- Pohlman, Brad L
- Flinn, Ian W
- Forero-Torres, Andres
- Enas, Nathan H
- Cronier, Damien M
- Dang, Nam H
- Foon, Kenneth A
- Carpenter, Susan P
- Slapak, Christopher A
- Link, Brian K
- Smith, Mitchell R
- Mapara, Markus Y
- Wooldridge, James E
Producer: 20151007
In:
Leukemia & lymphoma vol. 56
Availability: No items available.
|
|
18.
|
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma. [electronic resource] by
- Robertson, Michael J
- Kahl, Brad S
- Vose, Julie M
- de Vos, Sven
- Laughlin, Mary
- Flynn, Patrick J
- Rowland, Kendrith
- Cruz, Jose C
- Goldberg, Stuart L
- Musib, Luna
- Darstein, Christelle
- Enas, Nathan
- Kutok, Jeffery L
- Aster, Jon C
- Neuberg, Donna
- Savage, Kerry J
- LaCasce, Ann
- Thornton, Donald
- Slapak, Christopher A
- Shipp, Margaret A
Producer: 20070525
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 25
Availability: No items available.
|